BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wen C, Wang H, Wang H, Mo H, Zhong W, Tang J, Lu Y, Zhou W, Tan A, Liu Y, Xie W. A three-gene signature based on tumour microenvironment predicts overall survival of osteosarcoma in adolescents and young adults. Aging (Albany NY) 2020;13:619-45. [PMID: 33281116 DOI: 10.18632/aging.202170] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Wu F, Xu J, Jin M, Jiang X, Li J, Li X, Chen Z, Nie J, Meng Z, Wang G. Development and Verification of a Hypoxic Gene Signature for Predicting Prognosis, Immune Microenvironment, and Chemosensitivity for Osteosarcoma. Front Mol Biosci 2021;8:705148. [PMID: 35071320 DOI: 10.3389/fmolb.2021.705148] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Zhu Z, Zhang M, Wang W, Zhang P, Wang Y, Wang L. Global Characterization of Metabolic Genes Regulating Survival and Immune Infiltration in Osteosarcoma. Front Genet 2021;12:814843. [PMID: 35096022 DOI: 10.3389/fgene.2021.814843] [Reference Citation Analysis]
3 Qian H, Lei T, Hu Y, Lei P. Expression of Lipid-Metabolism Genes Is Correlated With Immune Microenvironment and Predicts Prognosis in Osteosarcoma. Front Cell Dev Biol 2021;9:673827. [PMID: 33937273 DOI: 10.3389/fcell.2021.673827] [Reference Citation Analysis]
4 Yang J, Zhang A, Luo H, Ma C. Construction and validation of a novel gene signature for predicting the prognosis of osteosarcoma. Sci Rep 2022;12:1279. [PMID: 35075228 DOI: 10.1038/s41598-022-05341-5] [Reference Citation Analysis]
5 Fan L, Ru J, Liu T, Ma C. Identification of a Novel Prognostic Gene Signature From the Immune Cell Infiltration Landscape of Osteosarcoma. Front Cell Dev Biol 2021;9:718624. [PMID: 34552929 DOI: 10.3389/fcell.2021.718624] [Reference Citation Analysis]
6 Zou T, Liu W, Wang Z, Chen J, Lu S, Huang K, Li W. C3AR1 mRNA as a Potential Therapeutic Target Associates With Clinical Outcomes and Tumor Microenvironment in Osteosarcoma. Front Med (Lausanne) 2021;8:642615. [PMID: 33748161 DOI: 10.3389/fmed.2021.642615] [Reference Citation Analysis]
7 Zheng D, Yang K, Chen X, Li Y, Chen Y. Analysis of Immune-Stromal Score-Based Gene Signature and Molecular Subtypes in Osteosarcoma: Implications for Prognosis and Tumor Immune Microenvironment. Front Genet 2021;12:699385. [PMID: 34630511 DOI: 10.3389/fgene.2021.699385] [Reference Citation Analysis]
8 Zhang Z, Liu X, Cheng D, Dang J, Mi Z, Shi Y, Wang L, Fan H. Unfolded Protein Response-Related Signature Associates With the Immune Microenvironment and Prognostic Prediction in Osteosarcoma. Front Genet 2022;13:911346. [PMID: 35754801 DOI: 10.3389/fgene.2022.911346] [Reference Citation Analysis]
9 Wang Q, Zhang W, Guo Y, Li Y, Fu K. Development of an immune-related signature for predicting survival outcome and immunotherapy response in osteosarcoma. Aging (Albany NY) 2021;13:24155-70. [PMID: 34747719 DOI: 10.18632/aging.203671] [Reference Citation Analysis]